AI glasses concept stocks continued to rise, with Zhongke Lanxun, Hengxuan Technology and Mingyue Lens rising more than 12%, while Tianjian, Xingxing Technology, Yiyuan Communication, Yitong Communication and Zhuoyi Technology had previous daily limit.According to Tesla, from December 2 to December 8, Tesla sold 21,900 units in China, the highest weekly sales since the fourth quarter of this year. Up to now, Model Y has sold more than 556,000 vehicles.The semiconductor concept oscillated higher and Broadcom integrated daily limit, and the semiconductor concept oscillated higher and Broadcom integrated daily limit. Hengxuan Technology, Purran, Shanghai Beiling, Tailingwei and Dongxin shares rose more than 5%.
Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.Knight Frank: It is expected that Hong Kong's property prices will rise by up to 5% next year. Knight Frank released the "China Mainland and Hong Kong Property Market Outlook in 2025". It is estimated that Hong Kong's general residential property prices will rise by 5% and rents will rise by 3% to 5% next year; The property price of luxury houses remained stable, and the rent was flat to rise by 3%. Wang Zhaoqi, senior director of Knight Frank and head of the research and consulting department in Greater China, said that the Hong Kong property market is slightly affected by external factors. At present, the factors affecting the property market mainly come from domestic demand and supply. It is expected that the tone of the property market will be better in 2025 than this year, but because the cargo volume is still at a high level, the developer's goal is still to destock. With the interest rate falling further, it is expected that developers will accelerate the pace of pushing new offers and attract buyers with more concessions and financial plans.Hanwei Technology and others set up a new company in Hubei, including geographic remote sensing information service business. The enterprise search APP shows that recently, Hubei Hanwei Water Technology Co., Ltd. was established, with Zhao Shuai as the legal representative and a registered capital of 10 million yuan. Its business scope includes: intelligent instrument manufacturing; Industrial automatic control system device manufacturing; Research and development of mechanical equipment; Intelligent control system integration; Internet of things equipment sales; Geographic remote sensing information service, etc. Enterprise survey shows that the company is jointly owned by Hanwei Water Technology (Henan) Co., Ltd. and Li Yuhua, a subsidiary of Hanwei Technology.
Pan American Health Organization (PAHO): The number of cases of dengue fever in America exceeded 12.6 million this year. On the 10th, PAHO reported that the number of cases of dengue fever reported in America this year reached a record of more than 12.6 million, including 21,000 severe cases and over 7,700 deaths. According to a statement issued by the Pan-American Health Organization on the same day, this year, the most serious dengue fever epidemic broke out in the Americas since records began in 1980. The impact of this epidemic on Brazil, Argentina, Colombia and Mexico is particularly serious. These four countries account for 90% of the total number of cases and 88% of the total number of deaths in this region.A court in Hong Kong dismissed the liquidation case against Territorial Holdings, and a court in Hong Kong dismissed the liquidation case after the petition against Territorial Holdings, a real estate developer in China, was revoked. Our headquarters finance group withdrew the petition, and the debts and expenses have been settled. The liquidation petition was filed in September, involving an outstanding sum of HK$ 275,633.29. (Interface News)Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.
Strategy guide
12-14
Strategy guide